# Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.

> **NCT03773822** · PHASE3 · COMPLETED · sponsor: **CMC Ambroise Paré** · enrollment: 380 (actual)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **COMBINATION_PRODUCT:** Hydrocortisone + Flucortac
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03773822
- **Lead sponsor:** CMC Ambroise Paré
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-19
- **Primary completion:** 2023-04-05
- **Final completion:** 2023-04-05
- **Target enrollment:** 380 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03773822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03773822, "Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03773822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*